A Parallel-Group, Double-Blind Study to Investigate the Safety and Tolerability of a GLP-1 Product Compared with Placebo in Adult Participants Aged 55 to 80 Years with a BMI of 22 to 25 kg/m2.
The study involves up to 20 visits to our clinic in Guelph, ON. You may be in the study for up to 60 weeks including a screening period (up to 8 weeks), a treatment period (48 weeks) and a follow-up period (4 weeks). If you do not complete a pre-screening, there will be 19 visits. You will receive reasonable compensation for your time and travel to the clinic.
The primary purpose of this study is to assess the safety and tolerability of a new investigational drug compared to placebo (inactive product). In addition, this study will assess changes in weight and body composition, physical mobility, health-related quality of life, lipid levels, glycemic control, and cognitive health
Only a limited amount of spots available.
You may be eligible if you are:

Between 55 to 80 years old

Have a BMI between 22 to 25kg/m2

In good general health

NOT taking any medications/supplements for the promotion of weight loss or weight gain

Have a stable body weight (over past 3 months)
GLP-1 Healthy Weight Study
Participation will include:
- Up to 20 visits to our clinic (Guelph, ON)
- 48 weeks of oral study product consumption
- Blood draws
- 3 body composition scans (to assess body fat and lean mass)
- 2 Oral Glucose Tolerance Tests
- Fasting prior to all in-clinic visits
How it works:
Facility Features
We take pride in our bright, modern clinic that we continue to upgrade to ensure a comfortable clinical trial experience for you. Click here to take a virtual tour of our space.

Free wifi available throughout facility

Accessible facility

Private rooms available for calls

Certified, experienced and friendly staff

Comfortable seating options

24/7 access to staff
The Team Behind the Scenes
At Apex Trials, your safety is our top priority. Our team of qualified staff are here to ensure everything runs smoothly.